The desire to limit narcotic use, coupled with a desire for efficacious pain relief with few side effects, has led researchers and providers alike to focus on the possibilities inherent in the exploitation of the endocan¬nabinoid system. In particular, fatty acid amide hydrolase (FAAH) inhibitors and monoamine glycerol lipase (MAGL) inhibitors hold great potential to become some of the next new classifications of pharmaceuticals formulated for not only pain relief, but a host of other conditions as well. This course is designed to introduce the reader to the endocannabinoid system, its components and mechanism of action, and exam¬ine how its effects are currently employed in anesthe¬sia. Results from preclinical and clinical trials will be analyzed. In addition, concerns regarding long-term effects from the activation.

Learning Outcome(s):

1. Describe the endocannabinoid system, its components, and their mechanisms of action.
2. Discuss past and present utilization of the endocannabinoid system for analgesia and anesthesia.
3. Discuss the types of conditions being explored for treatment by pharmacological endocannabinoid manipulation.
4. Examine barriers to development of drugs that enhance the endocannabinoid system.
5. Discuss concerns regarding neuroplasticity of the EC system due to long-term activation.

This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1040716; Expiration Date 5/31/2024.

Brandy Flanagan, DNAP, CRNA

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.